Torre Lazur McCann Healthcare Group was named AOR for Entereg—the first and only FDA-approved agent indicated to accelerate the time to upper and lower GI recovery following partial large or small bowel resection surgery with primary anastomosis—and will re-launch the brand for GlaxoSmithKline and Adolor.

Meanwhile, its sister agency, Torre Lazur McCann London, won the global launch for a new contraceptive by Bayer Schering Pharma, plus the re-launch across Europe of Invega for schizophrenia, an atypical antipsychotic that helps treat both the “positive” and the “negative” symptoms of schizophrenia.